Horizon 2020 is the novel EU funding programme for Research and Innovation extending from 2014 until 2020 with a €80 billion budget. The first calls for proposals for Horizon 2020 were published on December 11, 2013. Its simplified rules, application submission process and grant management tools should facilitate achievement of participants' goals. For practical guidance, see the H2020 online manual.
H2020 supports SMEs with a new instrument that runs throughout various funded research and innovation fields, which helps SMEs to find more opportunities in various calls.
Additionally, H2020 aims to enhance the EU international research cooperation in order to create more opportunities for participation of Third Countries.
Since H2020 is built around the main societal challenges like ageing population, food security and energy efficiency, the EU prioritizesintegration of social sciences and humanities into its work programme.
Responding to the global health and care challenges, Research and Innovation (R&I) programme under Horizon 2020 is an investment in better health for all. R&I aims to keep the elders active and independent for longer and supports development of new, safer and more effective interventions. Additionally, R&I contributes to the sustainability of health and care systems.
During the first two years of Horizon 2020 (Work Programme for 2014/15), the EU will invest some €1 200 million in this Challenge.
Personalising health and care
Research and Innovation which is supported by this call will:
* improve our understanding of the causes and mechanisms underlying health, healthy ageing process and various diseases;
* improve our ability to monitor health and prevent, detect, treat and manage diseases;
* support the elders in leading an active and healthy lifestyle;
* test and demonstrate new models and tools for delivering health and care.
R&I supported by this call will leverage activities of the Member States in such fields as neuroscience, cancer and systems medicine. It will contribute to the European and international initiatives such as the European Innovation Partnership on Active and Healthy Ageing, the Global Alliance for Chronic Diseases, the Joint Programming Initiative "More Years, Better Lives - the Challenges and Opportunities of Demographic Change" and the Joint Programming on Neurodegenerative Diseases Research.
Several activities which are not included in the 2014/15 work programme will also be part of the "Health, demographic change and wellbeing" challenge, notably the Innovative Medicines Initiative, the European and Developing Countries Clinical Trials Partnership (EDCTP), and the Active and Assisted Living Programme.